Hyperandrogenism in PCOS

Diagnosis and Management of Polycystic Ovary Syndrome

Volumn , Issue , 2009, Pages 105-110

  Georgopoulos, Neoklis A ^a   Kandaraki, Eleni ^b   Panidis, Dimitrios ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051473826     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-09718-3_8     Document Type: Chapter

References (24)

1. Azziz R, Wonds KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1990;51:779-786.
3. Azziz R, Nestler HE, Dewailly D. Androgen excess disorders in Women. Polycystic Ovary Syndrome and Other Disorders. Humana Press, Totowa, New Jersey, USA, second edition, 2006.
4. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
5. Hassa H, Tanir H, Yildirim A, Senses T, Eskalen M, Mutlu FS. The hirsutism scoring system should be population specific. Fertil Steril 2005;84:778-780.
6. Nikolaou D, Gilling-Smith C. Hirsutism. Current Obstertrics and Gynecology 2005;15:174-182.
7. Carmina E, Rosato F, Janni À, Rizzo M, Longo RA. Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism. J Clin Endocrinol Metab 2006;91:2-6
8. Slayden SM, Moran C, Sams Jr WM, et al. Hyperandrogenemia in patients presenting with acne. Fertil Steril 2001;75:889-892.
9. Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecological Endocrinology 2002;16:275-284.
10. Carmina E, Lobo RA. Evidence for Increased Androsterone Metabolism in Some NormoandrogenicWomen with Acne. J Clin Endocrinol Metab 1993;76:1111-1114.
11. Cela E, Robertson C, Rush K, et al. Prevalence of polycystic ovaries in women with androgenic alopecia. Europ J Endocrinol 2003;149:439-442.
12. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 2007;92:405-413.
13. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinaemia on serum sex-hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:83-89.
14. Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I. Association of the (TAAAA) n repeat polymorphism in the sex hormonebinding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J Clin Endocrinol Metab 2003;88(12):5976-5980.
15. Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol 2004;18(5):685-706.
16. Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2005;62(6):644-649.
17. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
18. Azziz R, Black V, Hines GA, Fox LM, Boots LR. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1998;83(7):2317-23.
19. Carmina E, Lobo RA. Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients. Gynecol Endocrinol 1990;4(4):225-32.
20. Moran C, Reyna R, Boots LS, Azziz R. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil Steril 2004;81(1):126-31.
21. Hines GA, Smith ER, Azziz R. Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies. Fertil Steril 2001;76(4):730-735
22. Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metabol 1999;84(1):38-43
23. Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine 2006;30(1):19-26.
24. Escobar-Morreale HF, Luque-Ramírez M, San Milĺan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005;26(2):251-82.